QCG
SRTA

Quadrant Capital Group’s Strata Critical Medical Inc SRTA Stock Holding History

Quadrant Capital Group’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-551
Closed -$2.3K – 1422
2026
Q1 		$2.3K Buy
+551
New +$2.65K ﹤0.01% 2487

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quadrant Capital Group's SRTA Position: Q2 2026 in Review

Quadrant Capital Group sold out of Strata Critical Medical Inc (SRTA) in Q2 2026, closing a stake of 551 shares — an estimated $2.3K sold.

Quadrant Capital Group first reported a position in SRTA in Q1 2026 and held it in 1 quarter. The position peaked at $2.3K in Q1 2026. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Quadrant Capital Group reported no remaining Strata Critical Medical Inc position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 551 Strata Critical Medical Inc shares in Q2 2026, an estimated $2.3K.
  • Quadrant Capital Group first reported a position in Strata Critical Medical Inc in Q1 2026 and held it in 1 quarter.
  • Quadrant Capital Group's Strata Critical Medical Inc position peaked at $2.3K in Q1 2026.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.